Joseph Hernandez, Founder and CEO of Blue Water Vaccines discusses the company’s development of a universal influenza vaccine. Current research and development of this vaccine show that two doses are needed to focus the immune response on the regions of limited variability, which could provide life-long protection against influenza strains for most patients in comparison to the current yearly vaccine that’s administered, which only help about 50% of those who get it.
Joseph Hernandez M.S., M.B.A, Founder and CEO, is an entrepreneurial leader with over 25 years of experience in the healthcare field. He has a background in company creation and early stage technology development and has extensive experience in biology, epidemiology and molecular genetics. He is currently leading up a team that works alongside the University of Oxford and St. Jude’s Children’s Hospital and is looking to improve the global approach to attacking influenza infection and the burden it causes, both medically and economically.